Houston, TX (PRWEB) April 05, 2012
Nano3D BiosciencesTM (n3D), a company that specializes in three-dimensional (3D) cell culturing technology for the drug discovery, toxicology, and life science research markets, announces the release of its 24-well Bio-AssemblerTM.
“We are very excited about this product release as it represents a significant milestone for our company from both a scientific and business perspective. The 24-well platform is a major step forward, and will allow for higher throughput productivity. We expect that those in the drug discovery and toxicology screening markets will find this product of great interest,” said n3D CEO David Lee.
The Bio-AssemblerTM promotes the development and growth of 3D cellular structures through magnetic levitation. It uses a proprietary nanoparticle-based assembly called “Nanoshuttle-PL” to deliver magnetic nanoparticles to the cells. Preparation time and cell manipulation are very similar to that of 2D cell culture or conventional cell culturing methods, with the end result allowing for a more accurate representation of in vivo tissue. The technology is compatible with any media, diagnostic technique or cell type. Beyond the 24-well, our products also come in single-well and 6-well platforms.
n3D is proud to bring its groundbreaking solutions for 3D cell culturing to the drug discovery, toxicology, and life science research markets.
About n3D Biosciences
n3D is the award recipient of the Texas Emerging Technology Fund (TETF), National Science Foundation SBIR (Phase I and Phase II) awards, and the Goradia Innovation Prize. Located in Houston, TX this highly innovative biotech start-up is already making waves in the Biotechnology and Nanotechnology industry. Most recently, the company was featured in Nature Nanotechnology and MIT Technology Review (Bio-Assembling in 3-D with Magnetic Levitation - Technology Review) for its state-of-art 3D cell culturing technology.
# # #